Reuters · Andrew Silver ·

After China's anti-corruption crackdown on hospital visits and pharma reps, drugmakers are turning to AI assistants from Alibaba and others to reach physicians

Drugmakers in China are seizing on a boom in digital assistants that has opened up a new

In this story Alibaba

After China's anti-corruption crackdown on hospital visits and pharma reps, drugmakers are turning to AI assistants from Alibaba and others to reach physicians

Lead Source

Reuters — After China's anti-corruption crackdown on hospital visits and pharma reps, drugmakers are turning to AI assistants from Alibaba and others to reach physicians ↗

How this story grew

Coverage · 0 Discussion · 0

12:02 PM10:32 PM UTC

More

The American Bazaar: The American Bazaar

Unite.AI: Unite.AI

Related stories

Bloomberg: In a first-of-its-kind pilot in the US, Nolla Health will use AI to diagnose and prescribe acne medications to Utah patients without direct human oversight

Reuters: Analysis: AI-driven e-commerce adoption surged during China's month-long Singles Day festival, with event sales rising 2.4% between October 7 and October 31

Wall Street Journal: Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI-designed biotech drugs

Rest of World: Businesses in China are experimenting with ways to package and market AI tokens to ordinary consumers, including as credit card rewards and telecom plan bundles

Bloomberg: Alibaba's Alipay launches a new "all-in-one" platform for businesses to use AI agents to automate tasks; Alibaba's stock jumps 5%+ and is up 40%+ since June

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif